Paul Gilson

Paul Gilson has over 20 years of experience in the medical device industry. Paul is currently the Chairman at Bluedrop Medical.

Previously, Paul was the Chairman at Embo Medical, a company that develops and commercializes minimally invasive technologies for the treatment of cardiovascular diseases. Prior to that, they were the CSO at Novate Medical, a company that was acquired by BTG in 2018.

Before joining Novate, Paul held various positions at Proverum Medical, Selio Medical, Ostoform, and Veryan Medical.